HERMAN NDUNGU: Open Payments
NPI 1992345714 · ABINGDON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$909 in 26 payments from 6 companies in 2025. Trend: 2023 $96 · 2024 $203 · 2025 $909
Food & beverage: $797Education: $111
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 8 | $458 |
| Teva Pharmaceuticals USA, Inc. | 7 | $207 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $90 |
| Alkermes, Inc. | 4 | $74 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Janssen Scientific Affairs, LLC | 1 | $37 |
Products named: INVEGA SUSTENNA, CAPLYTA, ARISTADA, UZEDY, AUSTEDO XR, ABILIFY ASIMTUFII.
Industry payments across MD — which companies pay providers there.
